Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma
Open Access
- 6 July 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115096
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Environment-sensitive hydrogels for drug deliveryAdvanced Drug Delivery Reviews, 2012
- PPAR Medicines and Human Disease: The ABCs of It AllPPAR Research, 2012
- Long‐term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high‐grade, operable osteosarcomaCancer, 2012
- Production and properties of two collagenases from bacteria and their application for collagen extractionNew Biotechnology, 2011
- Human primary bone sarcomas contain CD133 + cancer stem cells displaying high tumorigenicity in vivoThe FASEB Journal, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Chemotherapy resistance in osteosarcoma: current challenges and future directionsExpert Review of Anticancer Therapy, 2006
- Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor MicroenvironmentMolecular Cancer Research, 2006
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976